ArticleClinical ophthalmology (Auckland, N.Z.)2025
Visual and Refractive Outcomes of a Hydrophobic Trifocal Diffractive Intraocular Lens in Eyes with Different Axial Lengths.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Potential Refractive Error Due to Axial Displacement of Intraocular Lenses with Clinically Relevant Compression Diameters.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To analyse the clinical outcomes of a hydrophobic trifocal diffractive intraocular lens (IOLs) implanted in eyes with different axial lengths. Methods: This prospective study enrolled 116 eyes implanted with the FineVision HP IOL (Beaver-Visitec International, Inc. USA). The eyes were allocated into 3 groups according to their preoperative axial length: Group A (21.00-22.50 mm, n=17), Group B (>22.50-24.00 mm, n=83), and Group C (>24.00-28.50 mm, n=16). Post-operative outcomes at 3 months considered manifest refraction, monocular LogMAR uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and uncorrected near visual acuity (UNVA) and distance-corrected near visual acuity (DCNVA, at 40 cm). Results: For Group A, 70.59% and 100% of eyes were within ±0.50D and ±1.00D, respectively (mean spherical equivalent [SE]: 0.23±0.39D); for Group B, these figures were 84.34% and 100%, respectively (mean SE: -0.12±0.41D); and for Group C, all eyes were within ±0.50D (mean SE: 0.16±0.21D). SE did not differ between groups (p>0.4). The mean CDVA was -0.01±0.07, -0.02±0.06, and -0.05±0.07 for Groups A, B, and C, respectively (p=0.147), and the mean DCNVA was 0.09±0.03, 0.08±0.05 and 0.09±0.03, respectively (p=0.716). For distance vision, in Group A, 76.47% and 100% of eyes had a cumulative CDVA of ≥20/20 and ≥20/25, respectively. These percentages changed to 92.77% and 100% for Group B, and 93.75% and 100% for Group C, respectively. For near vision, for Group A, 11.76% and 100% of eyes had a cumulative DCNVA of ≥20/20 and ≥20/25, respectively. These percentages changed to 18.07% and 100% for Group B, and 12.50% and 100% for Group C, respectively. Conclusion: The hydrophobic trifocal diffractive FineVision HP IOL provides good visual and refractive outcomes for eyes with different axial length.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.